FDA Investigator Paul L Figarole, Jr

Paul L Figarole, Jr has inspections in 10 countries as of 25 Aug 2023. Paul L Figarole, Jr has collaborated with a combinined 4224 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
103
Last Inspection Date:
25 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
100007211
Country:
United States of America, France, Germany, United Kingdom of Great Britain and Northern Ireland, Belgium, Italy, Switzerland, Canada, Spain, Netherlands
Co-Investigator(s):
Aaron J Fox, Abraham M Maekele, Adam M Derr, Adam R Cooke, Addam S Reynolds, Adetutu M Gidado, Amanda B Vega, Amir Alavi, Andria L Kuhlman, Angela E Glenn, Annemarie Bodnar, Ariel Cruz Figueroa, Azza Talaat, Barbara Janine Breithaupt, Barbara T Carmichael, Bill Tacket, Jr, Brant M Schroeder, Brian R Yaun, Brooke K Higgins, Burnell M Henry, Cary Greene, Caryn M Mcnab, CDR Ileana Barreto Pettit, Cheryl A Clausen, Christian D Lynch (CDL), Christos G Tsingelis, Colleen M Aspinwall, Connie R Kiessling, Constance Y Fears, Courtney A Gilbert, Courtney A Hunt, Craig A Garmendia, Cynthia Jim, CSO, Damaris Y Hernandez, Daniel C Kearns, Daniel J Lahar, Daryl A Dewoskin, David K Lau, David P King, Debra J Bennett, Dell S Moller, Denise M Digiulio, Diane Kelley, Dillard H Woody, Jr, Dionne D Arline, Donald M Mack, Donna Mwilliams Hill, Douglas C Kovacs, Dr. Dominick Roselle, Edmund F Mrak, Jr, Edward H Maticka, Edwin Melendez, Emest F Bizjak, Erika V Butler, Ernest A Clausnitzer, Gene R Gunn, Gerald B Seaborn, Jr, Geraldine D Sanders, Gerardo Z Vazquez, Gretchen M Laws, Gwyn G Dickinson, Hunt, Ivan E Reyes, Ivis Lnegron Torres, Jacqueline Mdiaz Albertini, James A Crim, James A Lane, James C Maclaughlin, James L Dunnie, Jr, James P Mcreavey, Jana L Caylor, Janete F Guardia, Jean A Peeples, Jennifer A Robinson, Jennifer D Hollstrom, Jennifer L Huntington, Jennifer Lalama, Jensel L Guadalupe, Jessica L Pressley, Joan A Loreng, Joanne E King, Jocelyn E Massey, Joey V Quitania, Jogy George, Jolanna A Norton, Jonee J Mearns, Jorge L Guadalupe, Jose Acruz Gonzalez, Jose E Melendez, DDC, Jose Martinez, Jr, Jose Perez Soto, Jose R Rodriguez, Joshua J Silvestri, Julie D Bringger, Junho Pak, Justin A Boyd, Karen E D'orazio, Karen G Hirshfield, Karl D Hezel, Katherine Szestypalow, Kathy E Craven, Kathy E Noe, Katie L Penno, Keith A Schwartz, Kelly I Anderson, Kenneth G Klobus, Kent C Faul, Kevin D Kallander, Kham Phommachanh, Kristin M Abaonza, Kristy A Zielny, Ladislav Kermet, Larry K Austin, Latorie S Jones, Laurie B Frazier, Laurie P Norwood, LCDR Michael H Tollon, Leo J Lagrotte, Leon L Law, Libia M Lugo, Linda F Murphy, Linda R Kuchenthal, Linda Thai, Lisa Hayka, Lisa Sg Shelton, Lourdes Andujar, LT Daveta L Bailey, LT Kimberly M Hull, LT Richard A Lyght, Lucas B Leake, Luella J Rossi, Luis A Dasta, Luis M Burgos Medero, Lundy H Patrick, Lura D Baquero, Lynne Ensor, Mabany Lizardi, Marcellinus D Dordunoo, Margarita Santiago, Marie Bbuen Bigornia, Marisol Faberlle, Marvin D Jones, Mary E Storch, Matthew B Casale, Meisha R Sampson, Meisha Waters, Melanie G Warzala, Melanie W Pishnery, Melissa J Garcia, Meyer J Slobotsky, Michael E Maselli, Michael R Goga, Michael Shanks, MS, Miguel A Martinez, Mihaly S Ligmond, Mizanne E Lewis, Moraima J Ramos Valle, Mpris Inspector, Mra Davism, Mra Mcculloughj, Nadeem I Chaudhry, Nancy A Saxenian Emmons, Nicolas Riveratorres, Nicole A Lloyd, Nicole E Knowlton, Nicole K Buck, Noreen Muniz, Noreen Muñiz, Norma Wong, Norman Wong, Omotunde O Osunsanmi, Patricia A Mcilroy, Patricia D Stahnke, Patricia H Dlugosz, Patsy J Domingo, Paul A Bonneau, Paul Mouris, Paula A Trost, Rachael A Moliver, Rafael E Arroyo, Ralph H Vocque, Ramesh Sood, Raymond T Oji, Rebecca E Dombrowski, Reyes Candau Chacon, PhD, Richard J Friedman, Richard K Vogel, Richard L Friedman, Richard Ledwidge (nmi), PhD, Robert C Coleman, Robert C Steyert, Robert J Ham, Robert J Martin, Rochelle K Kimmel, Rodney W Lenger, Ronald G Crawford, Ronald T Weber, Rosario D'costa, Rose M Ashley, Rose Xu, Roy R Rinc, Russell J Glapion, Saleem A Akhtar, Salvatore N Randazzo, Samantha J Bradley, Samantha J Pinizzotto, D V M, Santos E Camara, Saundrea A Munroe, Shari H Shambaugh, Shelby N Turner, Sheri L Stephenson, Sonya M Edmonds, State Agency, Steven A Brettler, Steven A Gonzales, Steven C Madzo, Susan M Jackson, Susanna E Ford, Analyst, Susanne M Richardson, MSc RAC ELS, Susant Hadman, Tim Lee, Traci M Armand, Tracy L Reed, Tricia S Martinez, Truong Xuan Nguyen (Andy), Valerie J Grecek Trinh, Victor J Gangi, Virginia L Meeks, Wayne E Seifert, Wendy G Tan, PhD, Xiaokuang Lai, PhD, Xiaoping Guan, Yasamin Ameri, Yumi J Hiramine, Zachary L Miller, Zada L Giles, Zakaria Wahba, Zhong Li, PhD

Paul L Figarole, Jr's Documents

Publish Date Document Type Title
December, 2004 EIR Dr. Herman Zaharowitz - EIR, 2004-12-03
January, 2003 EIR Sanofi Chimie - EIR, 2003-02-20
September, 2000 EIR OneBlood, Inc. - EIR, 2000-09-01
July, 2003 FDA 483 Suncare Medical, Inc. - Form 483, 2003-07-09
February, 2000 FDA 483 Phillips Pharmatech Labs, Inc. - Form 483, 2000-02-16
July, 2000 FDA 483 Response Catalent Pharma Solutions, LLC - Form 483R, 2000-08-01
September, 2000 FDA 483 EYE ASSOCIATES OF FORT MYERS - Form 483, 2000-09-27
January, 2003 FDA 483 Response Sanofi Chimie - Form 483R, 2003-03-07
May, 2002 FDA 483 Response Eli Lilly Italia SPA - Form 483R, 2002-05-24
January, 2002 FDA 483 Response Richard R. Caradonna, M.D. - Form 483R, 2002-03-11
March, 2002 EIR Bausch & Lomb Incorporated - EIR, 2002-03-19
September, 2000 FDA 483 Response OneBlood, Inc. - Form 483R, 2000-10-05
August, 2005 EIR VistaPharm, LLC - EIR, 2005-08-16
July, 2002 FDA 483 Response Pegasus Laboratories, Inc. - Form 483R, 2002-08-06
March, 2002 FDA 483 Newco Pharm LLC - Form 483, 2002-03-11
April, 2003 FDA 483 USF Institutional Review Board - Form 483, 2003-04-01
May, 2002 EIR Eli Lilly Italia SPA - EIR, 2002-08-01
September, 2000 EIR Cecil Beehler, M.D. - EIR, 2000-09-27
September, 2000 FDA 483 OneBlood, Inc. - Form 483, 2000-09-01
May, 2002 FDA 483 Response Lilly France - Form 483R, 2002-05-30
July, 2002 FDA 483 Pegasus Laboratories, Inc. - Form 483, 2002-07-23
December, 2002 EIR Jeffrey A. Hirschfield, M.D. - EIR, 2002-12-11
April, 2003 EIR USF Institutional Review Board - EIR, 2003-04-01
November, 2001 FDA 483 Bausch Health Companies Inc. - Form 483, 2001-11-08
July, 2000 EIR Catalent Pharma Solutions, LLC - EIR, 2000-07-21
June, 2001 FDA 483 Response Newco Pharm LLC - Form 483R, 2001-07-27
December, 2004 FDA 483 Dr. Arnaldo Torres - Form 483, 2004-12-01
December, 2004 FDA 483 Dr. Herman Zaharowitz - Form 483, 2004-12-03
July, 2000 FDA 483 Catalent Pharma Solutions, LLC - Form 483, 2000-07-21
September, 2000 FDA 483 Response OneBlood, Inc. - Form 483R, 2000-10-05
February, 2000 EIR Phillips Pharmatech Labs, Inc. - EIR, 2000-02-16
November, 2001 EIR Bausch Health Companies Inc. - EIR, 2002-01-10
September, 2001 EIR Edward Gillie, M.D. - EIR, 2001-09-19
October, 2001 EIR Dynamic Pharmaceuticals, Inc. - EIR, 2001-10-22
February, 2002 FDA 483 Terry Yon & Associates, Inc. dba Tya Pharmaceuticals - Form 483, 2002-02-15
November, 2002 FDA 483 Newco Pharm LLC - Form 483, 2002-11-12
July, 2003 FDA 483 Linde gas LLC - Form 483, 2003-07-21
April, 2001 EIR Winston E. I. Barzell, M.D. - EIR, 2001-04-19
January, 2002 FDA 483 Richard R. Caradonna, M.D. - Form 483, 2002-01-03
October, 2003 FDA 483 Wyeth Farma SA - Form 483, 2003-10-29
May, 2002 FDA 483 ELI LILLY ITALIA S.p.A. - Form 483, 2002-05-24
May, 2002 FDA 483 Lilly France - Form 483, 2002-05-14
October, 2003 FDA 483 Newco Pharm LLC - Form 483, 2003-10-16
January, 2005 EIR Catalent Pharma Solutions, LLC - EIR, 2005-01-14
November, 2001 FDA 483 Response Bausch Health Companies Inc. - Form 483R, 2001-11-21
May, 2002 EIR Lilly France - EIR, 2002-08-01
June, 2001 FDA 483 Newco Pharm LLC - Form 483, 2001-06-13

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more